ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

ESMO 2024 Insights: OS Results for Pembro + CRT for High-Risk Locall…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

Cancer Screening Molecular Tools

Fengting Yan

Induction CT Followed by Standard CRT vs. CRT Alone in Locally Advan…

Gemma Eminowicz

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

Updates in the Management of Locally Advanced Cervical Cancer

Jill Remick

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New…

2024 ESMO Annual Meeting Insights Hub

S. Banerjee

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns

Precision Medicine: Management of Cervical Cancer

Miami Cancer Institute Precision Oncology Symposium

J. Diaz

Successful Carboplatin Desensitization Protocol in Gynecologic Cance…

Mariateresa Lapresa

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/…

2024 ASCO® Annual Meeting Insights Hub

D. Dizon

Overview of Cervical Cancer Updates

Masonic Cancer Center, University of Minnesota

J. Mattson

ESMO 2024 Insights: Induction Chemo Followed by CRT in Advanced Cerv…

2024 ESMO Annual Meeting Insights Hub

G. Eminowicz

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following Chem…

Insights from 2024 SGO Annual Meeting

M. Kuznicki